Cargando…

Five Simple Steps to Optimize Bolus Insulin Therapy in Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Peters, Kyle R., Paulsen, Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Departments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391812/ https://www.ncbi.nlm.nih.gov/pubmed/28442827 http://dx.doi.org/10.2337/cd15-0059

Ejemplares similares

Implementation of a Multidisciplinary Educational Strategy Promoting Basal-Bolus Insulin Therapy Improves Glycemic Control and Reduces Length of Stay for Inpatients With Diabetes
por: Helmle, Karmon E., et al.
Publicado: (2019)

Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
por: Abrahamson, Martin J., et al.
Publicado: (2012)

Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy
por: Schmidt, Sierra C., et al.
Publicado: (2016)

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
por: Bergenstal, Richard M., et al.
Publicado: (2019)

Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes
por: Louise Walton, Emma
Publicado: (2018)

Optimal prandial timing of bolus insulin in diabetes management: a review
por: Slattery, D., et al.
Publicado: (2017)

Optimal Prandial Timing of Insulin Bolus in Youths with Type 1 Diabetes: A Systematic Review
por: Mozzillo, Enza, et al.
Publicado: (2022)

Missed Insulin Boluses for Snacks in Youth With Type 1 Diabetes
por: VanderWel, Brandon W., et al.
Publicado: (2010)

Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy: Impact of glycemic index and prandial bolus type
por: O'Connell, Michele A., et al.
Publicado: (2008)

Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes
por: Lingow, Sara E., et al.
Publicado: (2019)

The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
por: Ozturkmen, Yuksel Asli, et al.
Publicado: (2020)

Concurrence of Lipoatrophy and Lipohypertrophy in Children With Type 1 Diabetes Using Recombinant Human Insulin: Two Case Reports
por: Singha, Arijit, et al.
Publicado: (2016)

Preoperative Diabetes Optimization Program
por: Mendez, Carlos E., et al.
Publicado: (2018)

A Novel Approach to the Management of Neonatal Diabetes Using Sensor-Augmented Insulin Pump Therapy With Threshold Suspend Technology at Diagnosis
por: Marin, Monica T., et al.
Publicado: (2016)

A Case of Persistent Polyuria in an Insulin- Dependent Child With Diabetes
por: Mangaraj, Swayamsidha, et al.
Publicado: (2016)

Autoantibodies to Insulin and Dysglycemia in People With and Without Diabetes: An Underdiagnosed Association
por: Pavithran, Praveen Valiyaparambil, et al.
Publicado: (2016)

Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
por: Cobry, Erin C., et al.
Publicado: (2019)

Clinical and Roentgenological Profiles of Five Patterns of Charcot Foot in Diabetes: A Case Series
por: Chakraborty, Partha P., et al.
Publicado: (2016)

An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning
por: Zhu, Taiyu, et al.
Publicado: (2020)

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
por: Bellido, Virginia, et al.
Publicado: (2015)

Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes
por: Peters, Anne L., et al.
Publicado: (2019)

Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)
por: Philis-Tsimikas, Athena, et al.
Publicado: (2013)

Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes
por: Thalange, Nandu, et al.
Publicado: (2015)

Regular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
por: Sutton, David, et al.
Publicado: (2016)

A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
por: Candido, Riccardo, et al.
Publicado: (2018)

Euglycemic Diabetic Ketoacidosis Accompanied by Severe Hypophosphatemia During Recovery in a Patient With Type 2 Diabetes Being Treated With Canagliflozin/Metformin Combination Therapy
por: Shoukat, Sonia, et al.
Publicado: (2017)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus
por: Chawla, Rajeev, et al.
Publicado: (2021)

Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
por: Sangave, Nikhil A., et al.
Publicado: (2019)

Adding GLP-1 Receptor Agonist Therapy to Basal Insulin for Postprandial Glucose Control
por: Rhinehart, Andrew S.
Publicado: (2015)

Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy
por: Lopez, Prudence, et al.
Publicado: (2014)

Hemichorea-Hemiballism as the First Presentation of Type 2 Diabetes
por: Ray, Sayantan, et al.
Publicado: (2015)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
por: Pscherer, Stefan, et al.
Publicado: (2010)

Case Study: Use of GLP-1 Receptor Agonist in a Patient on Intensive Insulin Therapy
por: Wiley, Kenneth Calvin, et al.
Publicado: (2015)

Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes
por: Aronson, Ronnie, et al.
Publicado: (2020)

Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study
por: Takeshita, Yumie, et al.
Publicado: (2020)

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy
por: Langer, Jakob, et al.
Publicado: (2019)

Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy
por: Swan, Karena L., et al.
Publicado: (2009)

Mealtime insulin BOLUS score increases prior to clinic visits in youth with type 1 diabetes
por: McConville, Andrew, et al.
Publicado: (2020)

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
por: Lingvay, Ildiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hjni2vgo99n0ct647kdq49ihjm